PMID- 34368436
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240402
IS  - 2374-3735 (Print)
IS  - 2374-3743 (Electronic)
IS  - 2374-3735 (Linking)
VI  - 8
DP  - 2021
TI  - Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of 
      Barriers and Facilitators From Socioecological Perspectives.
PG  - 23743735211034338
LID - 10.1177/23743735211034338 [doi]
LID - 23743735211034338
AB  - Adherence to antidiabetic medications (ADMs) remains a serious challenge among 
      type 2 diabetes mellitus (T2DM) patients. Factors affecting medication adherence 
      are not fully understood in Nigeria. This qualitative study explored patients' 
      views on barriers and facilitators of medication adherence. Data collection was 
      through face-to-face, semistructured, in-depth interviews conducted on 25 
      purposively sampled patients attending a public tertiary hospital. The interviews 
      were audio recorded, transcribed verbatim, and analyzed using thematic analysis 
      based on socioecological framework. NVIVO version 10 identified more codes. Most 
      commonly identified barriers were organizational (clinic structure), personal 
      (perception of T2DM as a dangerous illness), interpersonal (lack of spousal 
      support), and community (concerns about taking ADMs in social gatherings). It was 
      observed that female patients received more spousal support than the males. The 
      facilitators of adherence include perceiving medication-taking a routine, the 
      need to live longer, having savings for ADMs, purchasing medications to last 
      until the next clinic visit. This study identified barriers and facilitators 
      unique to Nigerian T2DM patients. Interventions anchored on these factors would 
      improve medication adherence.
CI  - (c) The Author(s) 2021.
FAU - Onwuchuluba, E E
AU  - Onwuchuluba EE
AUID- ORCID: 0000-0003-3040-8122
AD  - Department of Clinical Pharmacy & Biopharmacy, Faculty of Pharmacy, University of 
      Lagos, Idi-araba, Lagos, Nigeria.
FAU - Oyetunde, O O
AU  - Oyetunde OO
AD  - Department of Clinical Pharmacy & Biopharmacy, Faculty of Pharmacy, University of 
      Lagos, Idi-araba, Lagos, Nigeria.
FAU - Soremekun, R O
AU  - Soremekun RO
AD  - Department of Clinical Pharmacy & Biopharmacy, Faculty of Pharmacy, University of 
      Lagos, Idi-araba, Lagos, Nigeria.
LA  - eng
PT  - Journal Article
DEP - 20210726
PL  - United States
TA  - J Patient Exp
JT  - Journal of patient experience
JID - 101688338
PMC - PMC8317237
OTO - NOTNLM
OT  - adherence
OT  - antidiabetic medications
OT  - barriers and facilitators
OT  - socioecological framework
COIS- Declaration of Conflicting Interests: The author(s) declared no potential 
      conflicts of interest with respect to the research, authorship, and/or 
      publication of this article.
EDAT- 2021/08/10 06:00
MHDA- 2021/08/10 06:01
PMCR- 2021/07/26
CRDT- 2021/08/09 06:44
PHST- 2021/08/09 06:44 [entrez]
PHST- 2021/08/10 06:00 [pubmed]
PHST- 2021/08/10 06:01 [medline]
PHST- 2021/07/26 00:00 [pmc-release]
AID - 10.1177_23743735211034338 [pii]
AID - 10.1177/23743735211034338 [doi]
PST - epublish
SO  - J Patient Exp. 2021 Jul 26;8:23743735211034338. doi: 10.1177/23743735211034338. 
      eCollection 2021.